114
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Environmental Metabolite, 1,2-Diacetylbenzene, Produces Cytotoxicity Through ROS Generation in HUVEC CellsFootnote

, , , , , & show all
Pages 1336-1343 | Published online: 24 Jul 2007
 

Abstract

Organic solvents are ubiquitous in industrial and household surroundings, and thus individuals are easily exposed. 1,2-Diethylbenzene (DEB) is one of organic solvents contained in gasoline or jet fuels. DEB is absorbed by dermal or inhalation routes, metabolized by cytochrome P-450 in the liver, and ultimately affects mammalian functions. 1,2-Diacetylbenzene (1,2-DAB), which is a putative metabolite of 1,2-DEB, resulted in neuropathological effects on rodent central and peripheral nervous systems. To elucidate the possibility of 1,2-DAB effects on the vascular system, studies were undertaken to examine whether 1,2-DAB induces endothelial cytotoxicity through reactive oxygen species (ROS) generation. Incubation of human umbilical vein endothelial cells (HUVEC) with lower concentrations (4 or 8 μM) of 1,2-DAB induced inhibition of cellular growth and at higher amounts (16 or 32 μM) produced apoptosis. Endothelial cells cultured with 1,2-DAB also showed increased intracellular ROS production and morphological alterations indicative of senescence. Pretreatment with the well-known antioxidant glutathione or N-acetylcysteine (NAC) reduced cytotoxicity induced by 1,2-DAB. Taken together, the results provide evidence that cytotoxicity induced by 1,2-DAB in endothelial cells may be mediated by ROS generation.

Notes

∗This study was supported by a Korean Research Foundation Grant funded by the Korean Government (MOEHRD), KRF-2005-041-E00131, and the Korea Science and Engineering Foundation (KOSEF) through the Aging-Associated Vascular Disease Research Center at Yeungnam University (R13-2005-005-01003-0 [2006]).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.